BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 36333740)

  • 1. Impact of suboptimal or inappropriate treatment on healthcare resource use and cost among patients with uncomplicated urinary tract infection: an analysis of integrated delivery network electronic health records.
    Shafrin J; Marijam A; Joshi AV; Mitrani-Gold FS; Everson K; Tuly R; Rosenquist P; Gillam M; Ruiz ME
    Antimicrob Resist Infect Control; 2022 Nov; 11(1):133. PubMed ID: 36333740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic burden of antibiotic-not-susceptible isolates in uncomplicated urinary tract infection: Analysis of a US integrated delivery network database.
    Shafrin J; Marijam A; Joshi AV; Mitrani-Gold FS; Everson K; Tuly R; Rosenquist P; Gillam M; Ruiz ME
    Antimicrob Resist Infect Control; 2022 Jun; 11(1):84. PubMed ID: 35701853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment patterns, healthcare resource use, and costs associated with uncomplicated urinary tract infection among female patients in the United States.
    Moon RC; Marijam A; Mitrani-Gold FS; Gibbons DC; Kartashov A; Rosenthal NA; Joshi AV
    PLoS One; 2022; 17(11):e0277713. PubMed ID: 36409679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uncomplicated urinary tract infections in Swedish primary care; etiology, resistance and treatment.
    Kornfält Isberg H; Melander E; Hedin K; Mölstad S; Beckman A
    BMC Infect Dis; 2019 Feb; 19(1):155. PubMed ID: 30760219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment Patterns and Adherence to Guidelines for Uncomplicated Urinary Tract Infection in Germany: A Retrospective Cohort Study.
    Krinner A; Schultze M; Marijam A; Pignot M; Kossack N; Mitrani-Gold FS; Joshi AV
    Infect Dis Ther; 2024 Jun; ():. PubMed ID: 38869841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current prescribing practices and guideline concordance for the treatment of uncomplicated urinary tract infections in women.
    Langner JL; Chiang KF; Stafford RS
    Am J Obstet Gynecol; 2021 Sep; 225(3):272.e1-272.e11. PubMed ID: 33848538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unmet needs in uncomplicated urinary tract infection in the United States and Germany: a physician survey.
    O'Brien M; Marijam A; Mitrani-Gold FS; Terry L; Taylor-Stokes G; Joshi AV
    BMC Infect Dis; 2023 May; 23(1):281. PubMed ID: 37138215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity impairment, health-related quality of life, productivity, and self-reported resource use and associated costs of uncomplicated urinary tract infection among women in the United States.
    Thompson J; Marijam A; Mitrani-Gold FS; Wright J; Joshi AV
    PLoS One; 2023; 18(2):e0277728. PubMed ID: 36724152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute uncomplicated UTI and E. coli resistance: implications for first-line empirical antibiotic therapy.
    Perfetto EM; Keating K; Merchant S; Nichols BR
    J Manag Care Pharm; 2004; 10(1):17-25. PubMed ID: 14720102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence, regional distribution, and trends of antimicrobial resistance among female outpatients with urine Klebsiella spp. isolates: a multicenter evaluation in the United States between 2011 and 2019.
    Kaye KS; Gupta V; Mulgirigama A; Joshi AV; Ye G; Scangarella-Oman NE; Yu K; Mitrani-Gold FS
    Antimicrob Resist Infect Control; 2024 Feb; 13(1):21. PubMed ID: 38355621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of Predictive Models to Inform a Novel Risk Categorization Framework for Antibiotic Resistance in E. coli-Causing Uncomplicated Urinary Tract Infection.
    Shields RK; Cheng WY; Kponee-Shovein K; Indacochea D; Gao C; Kuwer F; Joshi AV; Mitrani-Gold FS; Schwab P; Ferrinho D; Mahendran M; Pinheiro L; Royer J; Preib MT; Han J; Colgan R
    Clin Infect Dis; 2024 Apr; ():. PubMed ID: 38573310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Escherichia coli resistance, treatment patterns and clinical outcomes among females with uUTI in Germany: a retrospective physician-based chart review study.
    Naber KG; Wagenlehner F; Kresken M; Cheng WY; Catillon M; Duh MS; Yu L; Khanal A; Mulgirigama A; Joshi AV; Ju S; Mitrani-Gold FS
    Sci Rep; 2023 Jul; 13(1):12077. PubMed ID: 37495602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occurrence and Genomic Characterization of Clone ST1193 Clonotype 14-64 in Uncomplicated Urinary Tract Infections Caused by Escherichia coli in Spain.
    García-Meniño I; Lumbreras P; Lestón L; Álvarez-Álvarez M; García V; Hammerl JA; Fernández J; Mora A
    Microbiol Spectr; 2022 Jun; 10(3):e0004122. PubMed ID: 35604206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial Resistance Trends in Urine Escherichia coli Isolates From Adult and Adolescent Females in the United States From 2011 to 2019: Rising ESBL Strains and Impact on Patient Management.
    Kaye KS; Gupta V; Mulgirigama A; Joshi AV; Scangarella-Oman NE; Yu K; Ye G; Mitrani-Gold FS
    Clin Infect Dis; 2021 Dec; 73(11):1992-1999. PubMed ID: 34143881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Likelihood of Antimicrobial Resistance in Urinary E coli Isolates among US Female Patients with Recurrent vs Non-Recurrent Uncomplicated Urinary Tract Infection.
    Fromer DL; Cheng WY; Gao C; Mahendran M; Hilts A; Duh MS; Joshi AV; Mulgirigama A; Mitrani-Gold FS
    Urology; 2024 Mar; ():. PubMed ID: 38467284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The emotional impact of uncomplicated urinary tract infections in women in China and Japan: a qualitative study.
    Yun Z; Powell D; Mulgirigama A; Miyazaki J
    BMC Womens Health; 2024 Feb; 24(1):94. PubMed ID: 38321435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Empirical Antibiotic Therapy on Outcomes of Outpatient Urinary Tract Infection Due to Nonsusceptible
    Dunne MW; Puttagunta S; Aronin SI; Brossette S; Murray J; Gupta V
    Microbiol Spectr; 2022 Feb; 10(1):e0235921. PubMed ID: 35138150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reducing Antibiotic Duration for Uncomplicated UTI in the Pediatric Emergency Department.
    Kooner GK; Bass M; Saroha V; Gonzalez PJ; Jain S
    Hosp Pediatr; 2024 Apr; 14(4):265-271. PubMed ID: 38533560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. US-Focused Conceptual Health Care Decision-Analytic Models Examining the Value of Pivmecillinam Relative to Current Standard-of-Care Agents Among Adult Patients With Uncomplicated Urinary Tract Infections due to Enterobacterales.
    Lodise TP; Henriksen AS; Hadley T; Patel N
    Open Forum Infect Dis; 2021 Oct; 8(10):ofab380. PubMed ID: 34660834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of US Food and Drug Administration Removal of Indications for Use of Oral Quinolones With Prescribing Trends.
    Tran PT; Antonelli PJ; Hincapie-Castillo JM; Winterstein AG
    JAMA Intern Med; 2021 Jun; 181(6):808-816. PubMed ID: 33871571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.